Today, the Commission announces the first provisional results of the implementation of the Coronavirus Response Investment Initiative (CRII) and Coronavirus Response Investment Initiative Plus (CRII+).
More
Commissioners Ferreira, Sinkevičius and Breton will participate to the Outermost Regions Forum that will take place on 12, 13 and 14 October 2020 in a fully virtual mode under the headline “Together for a sustainable future”.
More
This morning, the President of the European Commission, Ursula von der Leyen, addressed the opening session of this year's edition of the European Week of Regions and Cities via videoconference.
More
One of the challenges of measuring the economy through the pandemic has been estimating the contribution of the public sector, when the relationship between public spending and outputs – for example classes taught or operations conducted – is very different from pre-COVID-19 times. Katherine Mills talks about how we’ve approached the issue.
More
A challenge faced by the ONS during the pandemic is the inability to conduct face-to-face household interviews, having to rely on telephone surveys instead. So we’ve been exploring how this might have affected responses to our Labour Force Survey on which the key UK employment data are based. Jonathan Athow explains what we have
More
Swirling fragments of past space endeavours are trapped in orbit around Earth, threatening our future in space. Over time, the number, mass and area of these debris objects grows steadily, boosting the risk to functioning satellites.
More
The government’s Job Support Scheme (JSS) will be expanded to protect jobs and support businesses required to close their doors as a result of coronavirus restrictions, the Chancellor announced today.
More
The agreement reached in Moscow overnight by Armenia and Azerbaijan puts us on the path towards the resumption of substantive negotiations in the agreed format
More
Six new projects worth a total of £2 million will give a much-needed boost in support for research investigating the impact of the COVID-19 pandemic on mental health.
More
In a continuing effort to provide the facts about ID NOW to support public health interests, Abbott (NYSE: ABT) is sharing new interim clinical data results on its ID NOW COVID-19 rapid test. The results confirm the data submitted to the U.S. Food and Drug Administration (FDA) in March for Emergency Use Authorization (EUA) and
More